Shirley R. Kuhlmann is CLO & VP at COLLEGIUM PHARMACEUTICAL, INC (COLL). They have made 7 open-market trades across 1 company since 2020, most recently 2025-03-06.
CIK 0001734919
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COLL | 108,137 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2025-03-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| COLL | SELL | 2025-03-04 | 2025-03-06 | $28.27 | $3.2M | +1.1% | -7.2% | -0.3% |
| COLL | SELL · 10b5-1 | 2025-01-10 | 2025-01-14 | $33.04 | $909K | +1.6% | -7.2% | -19.9% |
| COLL | SELL | 2024-09-05 | 2024-09-06 | $38.22 | $1.4M | +5.0% | +7.7% | -19.2% |
| COLL | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $32.56 | $1.6M | +0.6% | +1.8% | +18.3% |
| COLL | SELL · 10b5-1 | 2023-11-27 | 2023-11-29 | $25.78 | $660K | +8.1% | +20.3% | +43.8% |
| COLL | SELL · 10b5-1 | 2023-06-26 | 2023-06-28 | $21.68 | $750K | +0.0% | +4.2% | +2.5% |
| COLL | SELL | 2023-02-13 | 2023-02-14 | $26.88 | $1.2M | +0.8% | -8.6% | -11.7% |
| COLL | SELL | 2022-09-15 | 2022-09-16 | $18.07 | $1.4M | -5.1% | +6.8% | +31.6% |
| COLL | SELL · 10b5-1 | 2022-08-11 | 2022-08-15 | $20.01 | $6K | -2.6% | -2.7% | +6.5% |
| COLL | SELL | 2021-05-10 | 2021-05-12 | $22.77 | $159K | +12.2% | +7.0% | -12.9% |
| COLL | SELL | 2021-01-20 | 2021-01-22 | $24.45 | $297K | -3.3% | +3.2% | -2.4% |
| COLL | SELL | 2020-10-15 | 2020-10-16 | $20.82 | $294K | -14.0% | -9.1% | +6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.